(Date:12/1/2008)...f the National Cancer Institute,s cancer registry ...experience delayed or incomplete radiation treatme...his suboptimal care can lead to worse outcomes. ,... College and colleagues found that among a nationa...ancer registry patients aged 65 and older, almost ...
(Date:12/1/2008)..., Dec. 1 MassMutual Retirement Ser...pport its increasing nonprofit business. Nonprofit...o last year. , , Dan Darby joined MassMutu...r the Western region. He reports to M. Palmer Whit... for MassMutual,s Retirement Services Division, wh...
(Date:12/1/2008)... 1 Senetek PLC,(OTC Bul...ed in the,development of technologies that target...at Dynamics Group AG, specialists in the fields of...and research with offices in Zurich,Bern and Gen.... , The Research Report, available in the "...
(Date:12/1/2008)...eroids effective against plantar fasciitis, resear...y News) -- Italian researchers say they,ve develop...he painful foot condition known as plantar fasciit... steroid injections guided by ultrasound, the rese...uccess rate in tackling a condition that afflicts ...
Breaking Medicine News(10 mins):Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3...genes which are active in prostate cancer have bee...el, cancer tissue differs markedly from normal hea...rchers have now developed the tools that can visua...characterise the cancerous cell. Using microarray ...
...dabad-based Zydus Cadila Healthcare announced a st...eting and manufacturing of formulation brands and ...n's anti-hypertensive drug 'Aten' for Rs. 75 crore...n the cardiovascular segment. Aten, today, ranks w...
...g to a study, loss of muscle is not an inevitable ...t make new muscle protein fast enough and thereby ...he University of California shows that muscle prot...n over 70. In fact there is no difference in muscl...
... new war brewing! Neither in the devastated NewYor...ere in the commercial capital of India --- Mumbai....rmaceutical industry of the country and the RDCA o...he latter is a member body of over 5,000 retail dr...
Other Medicine News:(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
(Date:11/25/2008)...Call/ -- CardioVascular,BioTherapeutics, Inc. (OT...as,dosed the first patient in North America (NA) ...reat patients with severe coronary heart disease. ...nary heart Disease) trial will include,four rando...pproximately 120,patients with severe coronary he...
(Date:11/24/2008)...ess Month , , Oak Brook, Ill., Nov. 24 /PRN...astrointestinal Endoscopy (ASGE) and the Pancreati...er to raise awareness about pancreatic cancer, edu...s that are available for them. , , Pancreat...aths in the U.S. In 2008, an estimated 37,680 Amer...
(Date:11/24/2008)...ll/ - Predictive medicine company PreMD Inc. (TSX:...d into a fully funded collaborative clinical study...s. PreMD,s PREVU* skin cholesterol test will be us...,s skin care products in a European clinical study...ed by PreMD with the cosmetic company. , "This ...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate 2Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 13353 1Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 13353 2Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 13353 3San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 1San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 2San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 3Evolution of root nodule symbiosis with nitrogen fixing bacteria 2390 1Evolution of root nodule symbiosis with nitrogen fixing bacteria 2390 2Team probes mysteries of oceanic bacteria 2388 1Team probes mysteries of oceanic bacteria 2388 2... - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today...ed trials related to the Company,s products,will b...ch will be,held May 19-24, 2007. Digestive Disease...us meeting in the world for the GI,professional. E...,researchers and academics from around the world w...
...st 45% additional,reduction in patients, LDL-chole...ering therapies, CARLSBAD, Calif., May 17, 2007 /P... announced updated results from its ongoing,Phase ...omozygous,familial hypercholesterolemia (HoFH), in...the of Cardiology Annual Scientific Session,(ACC) ...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 9 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm.
Medicine Products: